Perioperative discontinuation of SGLT2-inhibitors and cardiac complications after noncardiac surgery: is postoperative treatment resumption the critical factor? Comment on Br J Anaesth 2026; 137: 440-9

By afschroeder • September 5, 2026

Kalanski S, Grogan T, Nourian MM, Neelankavil J, Joosten A. Perioperative discontinuation of SGLT2-inhibitors and cardiac complications after noncardiac surgery: is postoperative treatment resumption the critical factor? Comment on Br J Anaesth 2026; 137: 440-9. Br J Anaesth. 2026 Sep 4:S0007-0912(26)00604-5. doi: 10.1016/j.bja.2026.07.042. Epub ahead of print. PMID: 42697753.

Tags: cardiovascular complications, DOM STAT, General Internal Medicine, heart failure, noncardiac surgery, perioperative medicine, Publications, SGLT2 inhibitors, treatment interruption

Probable invasive Alternaria rhinosinusitis in a previously healthy patient diagnosed with heterozygous CARD9 deficiency and combined immunodeficiency

Luo J, Cushing TR, Bjella JD, Chung D, Saby AH. Refractory Thigh Pain Revealing Femoral Neuritis in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Case Report. Cureus.[...]

Natural History After Likely Cure Versus Recurrence After Prostate Radiotherapy (RAPTOR)

Roy S, Romero T, Roach M 3rd, Michalski JM, Joseph DJ, Dearnaley D, Tree AC, Hall E, Sydes MR, Incrocci L, Heemsbergen W, de Pos[...]

Integrating Rehabilitation in Cancer Care

Eapen BC. Integrating Rehabilitation in Cancer Care. Phys Med Rehabil Clin N Am. 2026 Nov;37(4):xiii-xiv. doi: 10.1016/j.pmr.2026.08.013. PMID: 42823040.